Gemfibrozil and Bladder cancer - a phase IV clinical study of FDA data

Summary:

Bladder cancer is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Bladder cancer when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Bladder cancer?

Bladder cancer is found to be associated with 729 drugs and 1,027 conditions by eHealthMe. Check the latest studies of Bladder cancer.

On Jul, 12, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 19 people (0.11%) have Bladder cancer.

Among these 19 people:

How long have people been on Gemfibrozil when they have Bladder cancer? *

What is the gender of people who have Bladder cancer when taking Gemfibrozil? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Bladder cancer when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

What are other side effects people have besides Bladder cancer? *

Heart Attack: 6 people, 31.58%
Cardiac Failure Congestive: 5 people, 26.32%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 5 people, 26.32%
Pulmonary Oedema (fluid accumulation in the lungs): 5 people, 26.32%
Renal Cyst (kidney cyst): 5 people, 26.32%
Confusional State: 5 people, 26.32%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 26.32%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 4 people, 21.05%
Liver Function Test Abnormal: 4 people, 21.05%
Dyspnea (difficult or laboured breathing): 4 people, 21.05%

What are the existing conditions these people have? *

Type 2 Diabetes: 5 people, 26.32%
Diabetes: 3 people, 15.79%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 5.26%
Speech Impairment (Adult) (inability to speak (adult)): 1 person, 5.26%
Neuralgia (pain in one or more nerves): 1 person, 5.26%
Interstitial Lung Disease: 1 person, 5.26%
Immunodeficiency Common Variable: 1 person, 5.26%
Ill-Defined Disorder: 1 person, 5.26%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 5.26%
Gait Disturbance: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Bladder cancer?

- Check whether Bladder cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Bladder cancer treatments and more:

Bladder cancer (75,593 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bladder cancer:

Bladder cancer (729 drugs)

Browse all the conditions that are associated with Bladder cancer:

Bladder cancer (1,027 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.